GlassScriptPhysician profile
Edward John Stanulevich
NPI 1598394835
$6,170.83
in general payments reported to CMS, 2019-2025
18 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.74 · 2021: $1,894 · 2022: $1,679 · 2023: $1,002 · 2024: $935 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,501.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $2,400.00 | 2021-2022 | |
| Stryker Corporation | $1,759.55 | 2020-2024 | Augment Injectable, Viaflow, N/A |
| Organogenesis INC. | $310.15 | 2024-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Convatec INC. | $261.93 | 2023-2025 | |
| Solventum Corporation | $247.31 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, Activ.A.C. Ion Progress |
| Paratek Pharmaceuticals, INC. | $243.53 | 2023-2025 | Nuzyra |
| Kerecis Limited | $182.07 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Paragon 28, INC. | $145.60 | 2023 | Portfolio |
| Smith+Nephew, INC. | $143.65 | 2021 | |
| Globus Medical, INC. | $125.69 | 2025 | Senza |
| Integra Lifesciences Corporation | $95.04 | 2022 | |
| Biotissue Holdings INC. | $92.12 | 2023 | |
| Depuy Synthes Sales INC. | $45.33 | 2022 | |
| Acera Surgical, INC. | $35.66 | 2022 | |
| Averitas Pharma INC. | $27.66 | 2024 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $21.54 | 2024 | Senza |
| Mimedx Group, INC. | $19.31 | 2025 | |
| Abbvie INC. | $14.69 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Stanulevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.